3,4-dihydroxyphenylacetic acid has been researched along with 5,6-dihydroxytryptamine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eaton, MJ; Lookingland, KJ; Manzanares, J; Moore, KE; Tian, Y | 1 |
| Bortel, A; Brus, R; Dabrowska, J; Drosik, M; Kostrzewa, RM; Kwiecinski, A; Nowak, P; Opara, J; Oswiecimska, J | 1 |
2 other study(ies) available for 3,4-dihydroxyphenylacetic acid and 5,6-dihydroxytryptamine
| Article | Year |
|---|---|
Characterization of opioid receptor-mediated regulation of incertohypothalamic dopamine neurons: lack of evidence for a role of 5-hydroxytryptaminergic neurons in mediating the stimulatory effects of morphine.
Topics: 3,4-Dihydroxyphenylacetic Acid; 5,6-Dihydroxytryptamine; Animals; Catheterization; Creatinine; Dopamine; Female; Hypothalamus; Hypothalamus, Middle; Injections, Intraventricular; Male; Morphine; Neurons; Rats; Receptors, Opioid; Receptors, Opioid, kappa; Receptors, Opioid, mu; Serotonin | 1992 |
Amphetamine and mCPP effects on dopamine and serotonin striatal in vivo microdialysates in an animal model of hyperactivity.
Topics: 3,4-Dihydroxyphenylacetic Acid; 5,6-Dihydroxytryptamine; Age Factors; Amphetamine; Animals; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Corpus Striatum; Disease Models, Animal; Dopamine; Female; Hydroxyindoleacetic Acid; Male; Microdialysis; Oxidopamine; Piperazines; Pregnancy; Rats; Rats, Wistar; Serotonin; Serotonin Receptor Agonists; Sympatholytics | 2007 |